Philadelphia, PA – Capstone Partners LLC, a leading investment banking firm, announced that it has successfully advised Avomeen Analytical Services (“Avomeen”) on its recapitalization with High Street Capital. The terms of the deal were not disclosed.
Avomeen specializes in providing outsourced formulation and product development life cycle support, and analytical laboratory and pharmaceutical testing services. With an exceptional scientific staff including 22 Ph.D. chemists, the Company has developed an unparalleled track record for successfully tackling the most complex analytical problems related to product development, formulation, quality and manufacturing. The Company offers a broad array of solutions for chemical analysis, method development and validation, deformulation (reverse engineering), product development, extractables and leachables analysis, stability and release testing and clinical trial manufacturing. Widely recognized as a leading expert in deformulation analysis, Avomeen has unique capabilities to separate, identify and quantitate ingredients in complex formulations. These intricate techniques are used to provide solutions involving competitive product analysis, batch-to-batch product variation, product failure and product contamination as well as the development of generics for patent expiring pharmaceutical products.